Bone marrow microvessel density in chronic myeloproliferative disorders: A study of 115 patients with clinicopathological and molecular correlations

British Journal of Haematology

Volumn 140, Issue 2, 2008, Pages 162-168

  Boveri, Emanuela ^a   Passamonti, Francesco ^a,b   Rumi, Elisa ^a   Pietra, Daniela ^a   Elena, Chiara ^a   Arcaini, Luca ^a   Pascutto, Cristiana ^a   Castello, Alessandro ^a   Cazzola, Mario ^a   Magrini, Umberto ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Angiogenesis; JAK2V617F; Myelofibrosis; Polycythemia; Thrombocythemia

Indexed keywords

JANUS KINASE 2; LACTATE DEHYDROGENASE;

ADULT; AGED; ANEMIA; ANGIOGENESIS; ARTICLE; BONE MARROW; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; MUTATION; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RANK SUM TEST; THROMBOCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BONE MARROW; CHRONIC DISEASE; FEMALE; HUMANS; JANUS KINASE 2; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; NEOVASCULARIZATION, PATHOLOGIC; POLYCYTHEMIA VERA; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 37249094036     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06885.x     Document Type: Article

References (29)

1. Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., Koller, C., Estrov, Z., O'Brien, S., Keating, M., Freireich, E. Albitar, M. (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 96, 2240 2245.
2. Arora, B., Ho, C.L., Hoyer, J.D., Mesa, R.A. Tefferi, A. (2004) Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia. Haematologica, 89, 1454 1458.
3. Campbell, P.J., Scott, L.M., Buck, G., Wheatley, K., East, C.L., Marsden, J.T., Duffy, A., Boyd, E.M., Bench, A.J., Scott, M.A., Vassiliou, G.S., Milligan, D.W., Smith, S.R., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Harrison, C.N. Green, A.R. (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366, 1945 1953.
4. Ciurea, S.O., Merchant, D., Mahmud, N., Ishii, T., Zhao, Y., Hu, W., Bruno, E., Barosi, G., Xu, M. Hoffman, R. (2007) Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 110, 986 993.
5. Elliott, M.A., Mesa, R.A., Li, C.Y., Hook, C.C., Ansell, S.M., Levitt, R.M., Geyer, S.M. Tefferi, A. (2002) Thalidomide treatment in myelofibrosis with myeloid metaplasia. British Journal Haematology, 117, 288 296.
6. Florena, A.M., Tripodo, C., Iannitto, E., Porcasi, R., Ingrao, S. Franco, V. (2004) Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. Haematologica, 89, 911 919.
7. Keith, T., Araki, Y., Ohyagi, M., Hasegawa, M., Yamamoto, K., Kurata, M., Nakagawa, Y., Suzuki, K. Kitagawa, M. (2007) Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. British Journal of Haematology, 137, 206 215.
8. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779 1790.
9. Marchetti, M., Barosi, G., Balestri, F., Viarengo, G., Gentili, S., Barulli, S., Demory, J.L., Ilariucci, F., Volpe, A., Bordessoule, D., Grossi, A., Le Bousse-Kerdiles, M.C., Caenazzo, A., Pecci, A., Falcone, A., Broccia, G., Bendotti, C., Bauduer, F., Buccisano, F. Dupriez, B. (2004) Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial. Journal of Clinical Oncology, 22, 424 431.
10. Mesa, R.A., Hanson, C.A., Rajkumar, S.V., Schroeder, G. Tefferi, A. (2000) Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood, 96, 3374 3380.
11. Mesa, R.A., Steensma, D.P., Pardanani, A., Li, C.Y., Elliott, M., Kaufmann, S.H., Wiseman, G., Gray, L.A., Schroeder, G., Reeder, T., Zeldis, J.B. Tefferi, A. (2003) A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood, 101, 2534 2541.
12. Ni, H., Barosi, G. Hoffman, R. (2006) Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis. American Journal of Clinical Pathology, 126, 241 247.
13. Panteli, K., Zagorianakou, N., Bai, M., Katsaraki, A., Agnantis, N.J. Bourantas, K. (2004) Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. European Journal of Haematology, 72, 410 415.
14. Panteli, K., Zagorianakou, N., Agnantis, N.J., Bourantas, K.L. Bai, M. (2005) Clinical correlation of bone marrow microvessel density in essential thrombocythemia. Acta Haematologica, 114, 99 103.
15. Passamonti, F., Vanelli, L., Malabarba, L., Rumi, E., Pungolino, E., Malcovati, L., Pascutto, C., Morra, E., Lazzarino, M. Cazzola, M. (2003) Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica, 88, 1123 1129.
16. + cells into peripheral blood in myeloproliferative disorders. Blood, 107, 3676 3682.
17. Ponzoni, M., Savage, D.G., Ferreri, A.J., Pruneri, G., Viale, G., Servida, P., Bertolini, F. Orazi, A. (2004) Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining. Modern Pathology, 17, 1513 1520.
18. Pruneri, G., Ponzoni, M., Ferreri, A.J., Decarli, N., Tresoldi, M., Raggi, F., Baldessari, C., Freschi, M., Baldini, L., Goldaniga, M., Neri, A., Carboni, N., Bertolini, F. Viale, G. (2002) Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. British Journal of Haematology, 118, 817 820.
19. Rajkumar, S.V., Leong, T., Roche, P.C., Fonseca, R., Dispenzieri, A., Lacy, M.Q., Lust, J.A., Witzig, T.E., Kyle, R.A., Gertz, M.A. Greipp, P.R. (2000) Prognostic value of bone marrow angiogenesis in multiple myeloma. Clinical Cancer Research, 6, 3111 3116.
20. Steurer, M., Zoller, H., Augustin, F., Fong, D., Heiss, S., Strasser-Weippl, K., Gastl, G. Tzankov, A. (2007) Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Human Pathology, 38, 1057 1064.
21. Tefferi, A. (2000) Myelofibrosis with myeloid metaplasia. New England Journal of Medicine, 342, 1255 1265.
22. Tefferi, A., Cortes, J., Verstovsek, S., Mesa, R.A., Thomas, D., Lasho, T.L., Hogan, W.J., Litzow, M.R., Allred, J.B., Jones, D., Byrne, C., Zeldis, J.B., Ketterling, R.P., McClure, R.F., Giles, F. Kantarjian, H.M. (2006a) Lenalidomide therapy in myelofibrosis with myeloid metaplasia. Blood, 108, 1158 1164.
23. Tefferi, A., Lasho, T.L., Schwager, S.M., Strand, J.S., Elliott, M., Mesa, R., Li, C.Y., Wadleigh, M., Lee, S.J. Gilliland, D.G. (2006b) The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer, 106, 631 635.
24. Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H.M., Barbui, T., Hanson, C.A., Barosi, G., Verstovsek, S., Birgegard, G., Mesa, R., Reilly, J.T., Gisslinger, H., Vannucchi, A.M., Cervantes, F., Finazzi, G., Hoffman, R., Gilliland, D.G., Bloomfield, C.D. Vardiman, J.W. (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood, 110, 1092 1097.
25. Thiele, J., Kvasnicka, H.M., Boeltken, B., Zankovich, R., Diehl, V. Fischer, R. (1999) Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study. Leukemia, 13, 1741 1748.
26. Thiele, J., Kvasnicka, H.M., Facchetti, F., Franco, V., van der Walt, J. Orazi, A. (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 1128 1132.
27. Vardiman, J.W., Harris, N.L. Brunning, R.D. (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100, 2292 2302.
28. Weidner, N. (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Seminars in Diagnostic Pathology, 10, 302 313.
29. Zhu, K., Amin, M.A., Zha, Y., Harlow, L.A. Koch, A.E. (2005) Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood, 105, 2343 2349.